Patents by Inventor Sean B. Joseph

Sean B. Joseph has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antiviral Prodrugs and Pharmaceutical Compositions Thereof
    Publication number: 20230390318
    Abstract: Diesters of 4?-ethynyl-2-fluoro-2?-deoxyadenosine and aqueous parenteral suspensions thereof provide extended in vivo viral suppression of human immunodeficiency virus (HIV).
    Type: Application
    Filed: August 15, 2023
    Publication date: December 7, 2023
    Inventors: Arnab K. Chatterjee, Anil K. Gupta, Anders M. Eliasen, Sean B. Joseph
  • ANTIVIRAL PRODRUGS AND PHARMACEUTICAL COMPOSITIONS THEREOF
    Publication number: 20220332751
    Abstract: Diesters of 4?-ethynyl-2-fluoro-2?-deoxyadenosine and aqueous parenteral suspensions thereof provide extended in vivo viral suppression of human immunodeficiency virus (HIV).
    Type: Application
    Filed: September 11, 2020
    Publication date: October 20, 2022
    Applicant: THE SCRIPPS RESEARCH INSTITUTE
    Inventors: Arnab K. CHATTERJEE, Anil K. GUPTA, Anders M. ELIASEN, Sean B. JOSEPH
  • ANTIVIRAL PRODRUGS AND FORMULATIONS THEREOF
    Publication number: 20220323476
    Abstract: Provided herein are compounds, compositions and methods of using thereof for treatment and/or prevention infections of viruses such as HIV and HBV by administering a certain esters and other derivatives of 4?-ethynyl-2-fluoro-2?-deoxyadenosine (EFdA) or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: September 11, 2020
    Publication date: October 13, 2022
    Applicant: THE SCRIPPS RESEARCH INSTITUTE
    Inventors: Arnab K. CHATTERJEE, Anil K. GUPTA, Anders M. ELIASEN, Sean B. JOSEPH
  • Reciprocal regulation of inflammation and lipid metabolism by liver X receptors
    Publication number: 20040259948
    Abstract: The present invention is related to the role of liver X receptors (LXRs) in inflammation and immunity. More particularly, methods are disclosed for identifying and using LXR agonists for the treatment of inflammatory processes.
    Type: Application
    Filed: January 12, 2004
    Publication date: December 23, 2004
    Inventors: Peter Tontonoz, Sean B. Joseph, Antonio Castrillo